The JAK/STAT pathway is persistently activated in many malignant solid tumors including lung cancer [20], breast cancer [21], colorectal cancer [22], head and neck cancer [23], pancreatic cancer [24], and some hematological diseases [25]. This evidence concerns the gene SOAT1 and colorectal cancer.